Global /China /Healthcare /Medical Distribution /600998

Jointown Pharmaceutical Group Co., Ltd.

600998

• SSE: 600998 • Delayed

5.17CNY -0.4%

0.7637 USD

As of 5 June 2026, Jointown Pharmaceutical Group Co., Ltd. has a market cap of $3.82B USD, ranking #4596 globally and #938 in China. It ranks #351 in the Healthcare sector, and #8 in the Medical Distribution industry.

Global Rank

4596

Country Rank

938

Sector Rank

351

Industry Rank

Key Stats

Market Cap

$3.82BUSD

25.88B CNY

Enterprise Value

$4.93BUSD

33.36B CNY

Revenue (TTM)

$24.25BUSD

164.16B CNY

EBITDA (TTM)

$713.22MUSD

4.83B CNY

Net Income (TTM)

$298.13MUSD

2.02B CNY

EBITDA Margin

2.9%

Profit Margin

1.2%

PE Ratio

13.3

Forward PE

14.9

PS Ratio

0.2

PB Ratio

0.7

EV/EBITDA

6.6

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Distribution

CEO

Yihua Gong open_in_new

Employees

30,169

Founded

1999

Website

jointown.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.4%	-3.4%	2%	-4.2%	2.8%	1.4%	4%	-16%	-17%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600998 九州通医药集团股份有限公司 Class A ISIN: CNE100000W45 Shares Out.: Shares Outstanding: 5.042B¹ Shares Float: 1.958B² TV: TradingView: SSE: 600998 SA: Stock Analysis: SHA: 600998 YF: Yahoo Finance: 600998.SS GF: Google Finance: SHA: 600998 BA: Barron's: 600998 MS: Morningstar: XSHG: 600998	5.17 CNY	TV: TradingView: SSE: 600998 SA: Stock Analysis: SHA: 600998 YF: Yahoo Finance: 600998.SS GF: Google Finance: SHA: 600998 BA: Barron's: 600998 MS: Morningstar: XSHG: 600998

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Jointown Pharmaceutical Group Co., Ltd.

Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added services; and digital logistics and supply chain solutions. The company was founded in 1999 and is headquartered in Wuhan, China.

Similar Companies

Industry: Medical Distribution (China)

Name	Market Cap (USD) diff.	PE	Country
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 96%	7.2	China
Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. SHE: 301584	$1.63B 11.06B CNY -57%	31.2	China
Shenzhen Neptunus Bioengineering Co., Ltd. SHE: 000078	$1.24B 8.37B CNY -68%	-	China
Shinva Medical Instrument Co.,Ltd. SSE: 600587	$1.23B 8.31B CNY -68%	17.9	China
Shanghai Haohai Biological Technology Co., Ltd. SSE: 688366	$1.22B 8.24B CNY -68%	35.2	China
Nanjing Pharmaceutical Group Company Ltd. SSE: 600713	$1.05B 7.12B CNY -72%	12.8	China

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 3K%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 1K%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 1K%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 122%	22.6	United States
Galenica AG SIX: GALE	$5.32B 4.2B CHF 39%	23.0	Switzerland
DKSH Holding AG SIX: DKSH	$4.85B 3.83B CHF 27%	18.9	Switzerland

chevron_leftBack